Market Research Logo

Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review

Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review

provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, central nervous systems, gallstone, gastrointestinal, glaucoma, gout, migraine, muscle relaxant, obesity, pain management, respiratory, thyroid deficiency and urinary. Lannett also offers laboratory services, product formulation and development services, granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells its pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Philadelphia, Pennsylvania, the US.

Lannett Company Inc Key Recent Developments

Aug 20,2018: Lannett announces preliminary fiscal 2018 fourth-quarter and full-year financial results
Aug 03,2018: Lannett Enters Licensing Agreement For Generic Concerta®, Methylphenidate Hydrochloride ER Tablets
Jul 23,2018: Lannett Announces Multiple Product Launches
Jun 29,2018: Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary
May 07,2018: Lannett Acquires Portfolio Of Generic Products From Endo International

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Lannett Company Inc - Key Facts
Lannett Company Inc - Key Employees
Lannett Company Inc - Key Employee Biographies
Lannett Company Inc - Major Products and Services
Lannett Company Inc - History
Lannett Company Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Lannett Company Inc - Business Description
Lannett Company Inc - Corporate Strategy
Lannett Company Inc - SWOT Analysis
SWOT Analysis - Overview
Lannett Company Inc - Strengths
Lannett Company Inc - Weaknesses
Lannett Company Inc - Opportunities
Lannett Company Inc - Threats
Lannett Company Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Lannett Company Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 20, 2018: Lannett announces preliminary fiscal 2018 fourth-quarter and full-year financial results
Aug 03, 2018: Lannett Enters Licensing Agreement For Generic Concerta®, Methylphenidate Hydrochloride ER Tablets
Jul 23, 2018: Lannett Announces Multiple Product Launches
Jun 29, 2018: Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary
May 07, 2018: Lannett Announces Fiscal 2018 Third-Quarter Financial Results
Apr 30, 2018: Lannett Announces Changes To Board Of Directors
Apr 20, 2018: Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Mar 12, 2018: Lannett Adds New Revenue Streams, Announces Agreements With Three Strategic Alliance Partners
Feb 07, 2018: Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings
Feb 01, 2018: Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Lannett Company Inc, Key Facts
Lannett Company Inc, Key Employees
Lannett Company Inc, Key Employee Biographies
Lannett Company Inc, Major Products and Services
Lannett Company Inc, History
Lannett Company Inc, Other Locations
Lannett Company Inc, Subsidiaries
Lannett Company Inc, Key Competitors
Lannett Company Inc, Ratios based on current share price
Lannett Company Inc, Annual Ratios
Lannett Company Inc, Annual Ratios (Cont...1)
Lannett Company Inc, Annual Ratios (Cont...2)
Lannett Company Inc, Interim Ratios
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Lannett Company Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Lannett Company Inc, Performance Chart (2014 - 2018)
Lannett Company Inc, Ratio Charts
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Lannett Company Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report